Paste your Google Webmaster Tools verification code here
Genetically engineered immune cells saves a little life!
Layla Richards is a one year old baby girl who was diagnosed with Acute Lymphoblastic Leukemia, the most common form of childhood leukemia, when she was 14 weeks old. As chemotherapy and a bone marrow transplant turned to be of no help, doctors at the Great Ormond Street Hospital (GOSH) in central London offered an experimental treatment which was still under development. Fortunately it worked. A ‘cell therapy treatment’ that has never been tested in people earlier saved Layla who was close to dying from cancer. It also represents one of the first times that a novel “genome editing” technique has been used to treat someone. Though Layla has displayed cutback since few months only, her doctors consider it as a remarkable outcome as she has not been helped by conventional therapies.
As this was the first time that the treatment had been used, we didn’t know if or when it would work and so we were over the moon when it did. – Professor Paul Veys, director of bone marrow transplant at GOSH and Layla’s head doctor.
Read More: Biotecnika Magazine- December 2015
Shekhar Suman is a Serial Entrepreneur and the Co-Founder of Biotecnika. Magazine is a way he wants to recraft the way industry opines and expresses its views. With years of experience under his belt, he captains the ship with prudence and perfection. He is the chief-editor of Biotecnika Magazine and a big inspiration to the bio-community.
Your email address will not be published. Required fields are marked *
Notify me of follow-up comments by email.
Notify me of new posts by email.
biutech is one of the best field for human civilisatin.human now a day ...
Please help me through biotech daily updates ...
"We cannot turn back the clock on agriculture and only use methods tha ...
That is a good tip particularly to those fresh to the blogosphere. Br ...
Marvelous, what a website it is! This blog provides helpful data to us ...
Budget 2016 | What is in store for life science industry?
MONSANTO – INDIA SPAT | would it risk GM prevalence in the country?
Dr. Reddy’s and TR-Pharm collaborate over BIOSIMILARS
Person-on-chip for better drug testing
Scientists pin point gene that makes you grey
2014 Powered By Wordpress, Goodnews Theme By Momizat Team